Table 1. Bridging therapy modalities and the number of treated nodules.
| Bridging therapy combo | No. of tumors treated | Radiographical response | Pathological response | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CR | PR | SD | PD | 0% | <80% | >80% | 100% | |||
| MWA | 3 | 2 | – | 1 | – | – | 1 | – | 2 | |
| RFA | 1 | 1 | – | – | – | – | – | – | 1 | |
| RFA/MWA | 2 | 2 | – | – | – | – | – | – | 2 | |
| SIR | 4 | 2 | – | 1 | 1 | – | 4 | – | – | |
| TACE | 38 | 21 | 1 | 9 | 7 | 5 | 14 | 9 | 10 | |
| TACE/ETOH | 2 | 1 | – | 1 | – | – | 1 | 1 | – | |
| TACE/RFA | 23 | 17 | 1 | 3 | 2 | 1 | 10 | 5 | 7 | |
| TACE/MWA | 4 | 2 | 1 | 1 | – | 1 | 1 | – | 2 | |
| TACE/SIR | 7 | 4 | – | 3 | – | – | 4 | – | 3 | |
| TACE/SBRT | 2 | 2 | – | – | – | – | 2 | – | – | |
| TACE/MWA/RFA | 2 | 2 | – | – | – | – | 1 | 1 | – | |
| TACE/MWA/ETOH | 1 | – | – | 1 | – | – | 1 | – | – | |
| TACE/RFA/ETOH | 2 | 1 | – | 1 | – | – | – | 2 | – | |
| TACE/RFA/SIR | 2 | 2 | – | – | – | – | 1 | – | 1 | |
MWA, microwave ablation; RFA, radiofrequency ablation; SIR, selective internal radiation therapy; TACE, transcatheter arterial chemoembolization; ETOH, alcohol ablation; SBRT, stereotactic body radiation therapy; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.